Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) — Press release – regulated information Continues to collaborate closely with European and U.S. regulators on the assessment of its inaugural biofungicide, EVOCA™*, receiving a recommendation for EU approval from the Dutch CTGB in January 2025, following the authorization of extensive demonstration trials in the Netherlands. Advanced the product pipeline with preliminary field trials for BioFun-6 exhibiting significant results and showcasing enhanced potential.
